Skip to content
healthcare.dev

Dr.Jucre Rebirth Sun Protection

NDC 83071-150, OCTINOXATE, HOMOSALATE, OCTISALATE, AVOBENZONE, ENSULIZOLE, OCTOCRYLENE, BEMOTRIZINOL, NIACINAMIDE, ADENOSINE, cream, from NATURECELL CO., LTD..

Product NDC
83071-150
Status
Listed
Labeler
NATURECELL CO., LTD.
Dosage form
CREAM
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83071-150 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OCTINOXATE7.3 g/100mL
  • HOMOSALATE6 g/100mL
  • OCTISALATE4.5 g/100mL
  • AVOBENZONE4 g/100mL
  • ENSULIZOLE3.5 g/100mL
  • OCTOCRYLENE2 g/100mL
  • BEMOTRIZINOL1.5 g/100mL
  • NIACINAMIDE2 g/100mL
  • ADENOSINE.04 g/100mL

Pharmacologic classes

Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]

Package NDCNDC-11Package
83071-150-02830710150021 CONTAINER in 1 CARTON (83071-150-02) / 65 mL in 1 CONTAINER (83071-150-01)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 83071-150 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83071-150 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83071-150. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.